Sai Parenterals Limited IPO
Sai Parenterals Limited was a mainboard IPO in the Pharmaceuticals sector, offered at ₹372–₹392 per share to raise ₹409 crore. The issue was subscribed 1.05× overall (QIBs 1.71×, NIIs 2.36×, retail 0.12×). It listed on 2 Apr 2026 and closed its first day at ₹406, a listing gain of +3.5% versus the ₹392 issue price. It now trades around ₹522 (+33.1% versus the issue price).
Frequently asked questions
- How many times was the Sai Parenterals Limited IPO subscribed?
- The Sai Parenterals Limited IPO was subscribed 1.05× overall — 1.71× in the QIB category, 2.36× among non-institutional investors, 0.12× in retail.
- What were the Sai Parenterals Limited IPO listing gains?
- Sai Parenterals Limited listed on 2 Apr 2026, closing its first day at ₹406 — a listing gain of +3.5% versus the ₹392 issue price.
- What were the retail allotment odds for the Sai Parenterals Limited IPO?
- Retail was subscribed 0.12×, so a single-lot application had roughly a 100% chance of allotment — most applicants were allotted, and allotment was finalised on 31 Mar 2026.
- What was the price band and lot size of the Sai Parenterals Limited IPO?
- The price band was ₹372–₹392 per share, with a minimum lot of 38 shares (₹14,896 at the upper band).
- Who were the registrar and lead manager for the Sai Parenterals Limited IPO?
- Bigshare Services Private Limited was the registrar, and Arihant Capital Markets was the book-running lead manager.